Le Page
E, Veillard
D, Laplaud
DA,
et al. Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial [published correction appears in Lancet. 2016 Jan 23;387(10016):340].
Lancet. 2015;386(9997):974–981. doi:
10.1016/S0140-6736(15)61137-0Google Scholar